Hematology, Anticoagulation, and Transfusion Safety

Hematology, Anticoagulation, and Transfusion Safety

Case anchor

A 69-year-old adult with atrial fibrillation is admitted for pneumonia and is taking apixaban at home. The patient now has creatinine 2.0 mg/dL, hemoglobin 7.8 g/dL, platelets 88,000/mm3, black stool, and new dizziness when standing. This is not simply an anemia question. The CMSRN nurse evaluates oxygen delivery, active bleeding, anticoagulant effect, renal clearance, fall risk, and whether transfusion or urgent escalation is needed.

Anemia and oxygen delivery

Anemia assessment includes fatigue, dyspnea, chest pain, palpitations, dizziness, syncope, pallor, tachycardia, orthostatic hypotension, and activity tolerance. Hemoglobin values matter, but symptoms and comorbid disease guide urgency. A patient with coronary artery disease and chest pain at hemoglobin 8.2 g/dL is more concerning than an asymptomatic stable patient with chronic anemia at the same value. Assess for bleeding sources: stool, urine, emesis, wounds, drains, menstrual history, bruising, and medication list.

Platelets, neutrophils, and safety

For thrombocytopenia, avoid rectal temperatures, unnecessary venipunctures, and medications that increase bleeding when possible. For neutropenia, fever may be the only sign of severe infection. Report fever immediately according to facility threshold and do not give antipyretics as a substitute for escalation.

Anticoagulation safety

Anticoagulants prevent or treat clots, but bleeding risk is constant. For heparin infusions, verify weight-based dosing, pump programming, line compatibility, aPTT or anti-Xa monitoring per protocol, platelet trends for heparin-induced thrombocytopenia, and signs of bleeding. For warfarin, monitor INR, diet consistency with vitamin K, interactions, and delayed onset. For direct oral anticoagulants, check renal and hepatic function, timing of last dose, procedure plans, and interactions. Low-molecular-weight heparin is affected by renal function and body size.

CMSRN questions often ask what to do with a concerning dose or lab. If a patient on warfarin has INR 5.8 with bleeding, hold the medication, notify the provider, and anticipate reversal orders. If a patient on heparin develops a platelet fall plus new thrombosis, suspect HIT and escalate. If a patient on apixaban has melena and hypotension, treat as possible major bleeding.

Transfusion basics

Before transfusion, verify consent, type and screen, baseline vitals, IV patency, blood product order, patient identification with another qualified person per policy, allergies, prior reactions, and need for premedication if ordered. Use appropriate tubing and normal saline. Start slowly and remain with the patient during the initial period per policy because many severe reactions begin early.

Monitor for fever, chills, back or flank pain, chest tightness, dyspnea, wheezing, hypotension, tachycardia, anxiety, hives, itching, dark urine, or sense of doom. If a reaction is suspected, stop the transfusion first, keep IV access open with normal saline using new tubing per policy, assess the patient, notify the provider and blood bank, recheck identifiers, and send required blood and urine specimens. Do not restart the transfusion unless the reaction is evaluated and an authorized order or policy permits.

Clot recognition and prevention

Deep vein thrombosis may present with unilateral swelling, pain, warmth, and increased calf or thigh circumference. Pulmonary embolism may present with sudden dyspnea, pleuritic chest pain, tachycardia, hypoxemia, cough, syncope, or anxiety. Prevention includes early ambulation, sequential compression devices when not contraindicated, hydration, and anticoagulants as ordered. Do not massage a painful swollen calf.

Patient education

Teach anticoagulated patients to report black stools, blood in urine, severe headache, falls, nosebleeds that do not stop, unusual bruising, or heavy bleeding. Review medication adherence, missed-dose instructions from the prescriber, interaction risks, alcohol moderation, and procedure notification. Teach transfusion recipients to report symptoms immediately rather than waiting for the nurse to return. For anemia, connect energy conservation with safety: sit before standing, use assistance, and report chest pain or severe shortness of breath.

Escalation cues

Escalate suspected transfusion reaction, active bleeding with instability, hemoglobin drop with symptoms, platelet count with bleeding, neutropenic fever, suspected PE, new neurologic deficit on anticoagulation, severe sickle cell pain with hypoxia, or signs of disseminated intravascular coagulation such as oozing from lines with abnormal coagulation labs. The safest CMSRN answer is often the one that stops exposure, supports circulation, protects oxygenation, and notifies the right team quickly.